 |
市場調查報告書
商品編碼
1741129
PCOS 診斷市場（按診斷測試類型、最終用戶和地區）PCOS diagnostic Market, By Type of Diagnostic Test, By End-User, By Geography |
||||||
價格
簡介目錄
PCOS 診斷市場規模預計在 2025 年達到 39 億美元，預計到 2032 年將達到 54.9 億美元，2025 年至 2032 年的年複合成長率為 5%。
| 報告範圍 | 報告詳細資訊 | ||
|---|---|---|---|
| 基準年 | 2024 | 2025年的市場規模 | 39億美元 |
| 效能數據 | 從2020年到2024年 | 預測期 | 2025年至2032年 |
| 預測期：2025-2032年年複合成長率： | 5.00% | 2032年價值預測 | 54.9億美元 |
多囊性卵巢症候群（PCOS）是一種荷爾蒙失調疾病，影響十分之一的育齡女性。它會導致月經不規則、生育能力下降以及臉部和身體毛髮增生。此疾病可導致月經不規則、排卵異常、雄性激素水平升高、卵巢增大、胰島素抗性。據了解，全球有500萬育齡女性受其影響。它還可能導致不孕症、類風濕性關節炎、高血壓、心臟病和糖尿病等嚴重併發症。
市場動態：
多囊性卵巢症候群 (PCOS) 病例激增、盛行率上升以及女性對 PCOS 症狀認知的提高，預計將在預測期內推動全球 PCOS 診斷市場的成長。肥胖、久坐的生活方式和荷爾蒙異常等其他因素也有望推動市場成長。
然而，治療多囊性卵巢症候群（PCOS）藥物的嚴格核准流程以及藥物的副作用預計將在預測期內阻礙全球 PCOS 診斷市場的成長。
例如，根據世界衛生組織（WHO）2023年6月28日提供的數據，多囊性卵巢症候群（PCOS）是一個重大的公共衛生問題，也是影響育齡婦女最常見的荷爾蒙失調之一。據估計，該疾病影響全球8-13%的育齡婦女，高達70%的病例未被診斷。 PCOS在某些族群中的盛行率更高，這些族群通常會經歷更多的併發症，尤其是與代謝紊亂相關的併發症。
本研究的主要特點
- 本報告對全球 PCOS 診斷市場進行了詳細分析，並給出了預測期（2025-2032 年）的市場規模和年複合成長率（CAGR%），假設 2024 年為基準年。
- 它揭示了不同領域的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。
- 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。
- 它根據公司亮點、產品系列、關鍵亮點、財務表現和策略等參數列出了全球 PCOS 診斷市場的主要企業簡介。
- 本報告的見解將使負責人和公司經營團隊能夠就未來的產品發布、類型升級、市場擴張和行銷策略做出明智的決策。
- 全球 PCOS 診斷市場報告迎合了該行業的各個相關人員，例如投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
- 相關人員將透過用於分析全球 PCOS 診斷市場的各種策略矩陣來做出決策。
目錄
第1章 調查目的與前提條件
- 研究目標
- 先決條件
- 簡稱
第2章 市場展望
- 報告描述
- 市場定義和範圍
- 執行摘要
- Coherent Opportunity Map（COM）
第3章市場動態、法規與趨勢分析
- 市場動態
- 驅動程式
- 多囊性卵巢症候群（PCOS）盛行率不斷上升
- 提高認知和早期診斷
- 診斷技術的進步
- 醫療成本上漲
- 限制因素
- 缺乏標準化的診斷標準
- 缺乏認知和診斷不足
- 成本和可負擔性
- 機會
- 提高對多囊性卵巢卵巢治療的認知
- 影響分析
- 主要亮點
- 監管情景
- 產品發布/核准
- PEST分析
- 波特分析
- 併購場景
第4章 PCOS 診斷市場-冠狀病毒 (COVID-19) 大流行的影響
- COVID-19流行病學
- 供需側分析
- 經濟影響
5. PCOS 診斷市場（依診斷測試類型），2020 年至 2032 年
- 荷爾蒙測試
- 影像檢查
- 血液檢查
- 骨盆腔檢查
- 基因檢測
- 其他測試
6. PCOS 診斷市場（按最終用戶分類），2020 年至 2032 年
- 醫院和診所
- 不孕不育診所
- 居家照護環境
- 診斷實驗室
7. PCOS 診斷市場（按地區分類），2020 年至 2032 年
- 北美洲
- 美國
- 加拿大
- 歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
- 亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太地區
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
- 中東
- 海灣合作理事會國家
- 以色列
- 其他中東地區
- 非洲
- 南非
- 北非
- 中部非洲
第8章 競爭態勢
- Hoffmann-La Roche Ltd
- Abbott
- Quest Diagnostics
- Thermo Fisher Scientific Inc.
- Siemens Healthineers
- Bio-Rad Laboratories
- Hologic, Inc.
- Vitrolife
- Myriad Genetics, Inc.
- Ansh Labs
- Diagnostica Stago Inc.
- Beckman Coulter, Inc.
- Randox Laboratories Ltd.
- GE Healthcare
- PrivaPath Diagnostics
- Laboratory Corporation of America Holdings
- SRL Diagnostics
第9章 章節
- 調查方法
- 關於出版商
簡介目錄
Product Code: CMI5850
Pcos Diagnostic Market is estimated to be valued at USD 3.9 Bn in 2025 and is expected to reach USD 5.49 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 3.9 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 5.00% | 2032 Value Projection: | USD 5.49 Bn |
PCOS is a hormonal disorder that affects 1 in 10 women of childbearing age. It can cause irregular periods, trouble getting pregnant, and hair growth on the face and body. This condition results in irregular menstrual cycles, abnormal ovulation, high androgen levels, enlarged ovaries, and insulin resistance. It has been found to affect 5 million women of reproductive age globally. It also causes serious complications such as infertility, rheumatoid arthritis, high blood pressure, heart disease, and diabetes.
Market Dynamics:
Surging cases of the PCOS condition, increasing prevalence of PCOS, and increased awareness among women about its symptoms are expected to drive growth of the global PCOS diagnostic market over the forecast period. Other factors, including obesity, a sedentary lifestyle, and hormonal disorders, are also expected to drive the market's growth.
However, stringent regulatory approval processes for PCOS disease drugs and the side effects of treatment drugs are expected to hinder growth of the global PCOS diagnostic market over the forecast period.
For instance, on June 28, 2023, according to data provided by the World Health Organization, PCOS a significant public health problem and is one of the commonest hormonal disturbances affecting women of reproductive age. The condition affects an estimated 8-13% of women of reproductive age, and up to 70% of cases are undiagnosed worldwide. The prevalence of PCOS is higher among some ethnicities, and these groups often experience more complications, as in particular those related to metabolic problems.
Key features of the study:
- This report provides in-depth analysis of the global PCOS diagnostic market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global PCOS diagnostic market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd, Abbott, Quest Diagnostics, Thermo Fisher Scientific, Inc., Siemens Healthineers, Bio-Rad Laboratories, Hologic, Inc., Vitrolife, Myriad Genetics, Inc., Ansh Labs, Diagnostica Stago Inc., Beckman Coulter, Inc., Randox Laboratories Ltd., GE Healthcare, PrivaPath Diagnostics, Laboratory Corporation of America Holdings, SRL Diagnostics
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global PCOS diagnostic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global PCOS diagnostic market
Detailed Segmentation:
- PCOS Diagnostic Market, By Type of Diagnostic Test:
- Hormone Test
- Imaging Tests
- Blood Tests
- Pelvic Examination
- Genetic Testing
- Other Tests
- PCOS Diagnostic Market, By End User:
- Hospitals and Clinics
- Fertility Clinics
- Homecare Settings
- Diagnostic Laboratories
- PCOS Diagnostic Market, By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profile:
- F. Hoffmann-La Roche Ltd
- Abbott
- Quest Diagnostics
- Thermo Fisher Scientific, Inc.
- Siemens Healthineers
- Bio-Rad Laboratories
- Hologic, Inc.
- Vitrolife
- Myriad Genetics, Inc.
- Ansh Labs
- Diagnostica Stago Inc.
- Beckman Coulter, Inc.
- Randox Laboratories Ltd.
- GE Healthcare
- PrivaPath Diagnostics
- Laboratory Corporation of America Holdings
- SRL Diagnostics
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market PCOS Diagnostic, By Type of Diagnostic Test
- Market PCOS Diagnostic, By End User
- Market PCOS Diagnostic, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Increasing Prevalence of PCOS
- Growing Awareness and Early Diagnosis
- Technological Advancements in Diagnostics
- Rising Healthcare Expenditure
- Restraints
- Lack of Standardized Diagnostic Criteria
- Limited Awareness and under diagnosis
- Cost and Affordability
- Opportunities
- Growing awareness about polycystic ovarian syndrome treatment
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. PCOS Diagnostic Market - Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply Side and Demand Side Analysis
- Economic Impact
5. PCOS Diagnostic Market, By Type of Diagnostic Test, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hormone Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Imaging Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Blood Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Pelvic Examination
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Genetic Testing
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Other Tests
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
6. PCOS Diagnostic Market, By End User, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
- Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Fertility Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Homecare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
7. PCOS Diagnostic Market, By Region, 2020-2032, (US$ Bn)
- Introduction
- Market Share Analysis, By Country, 2023and 2032 (%)
- Y-o-Y Growth Analysis, For Country 2021-2032
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Diagnostic Test, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Diagnostic Test, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Diagnostic Test, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Diagnostic Test, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Diagnostic Test, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type of Diagnostic Test, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Quest Diagnostics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Bio-Rad Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Hologic, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Vitrolife
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Myriad Genetics, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Ansh Labs
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Diagnostica Stago Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Beckman Coulter, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Randox Laboratories Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- GE Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- PrivaPath Diagnostics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Laboratory Corporation of America Holdings
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- SRL Diagnostics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
9. Section
- Research Methodology
- About us
